3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Breast
2
Endocrine
1
Conditions
Breast Neoplasms
41
Neoplasm Metastasis
11
Hereditary Sensory and Autonomic Neuropathies
6
Squamous Cell Carcinoma of Head and Neck
5
Recurrence
5
Ovarian Neoplasms
5
Neoplasms
5
Triple Negative Breast Neoplasms
3
Multiple Endocrine Neoplasia Type 1
3
Head and Neck Neoplasms
3
Pancreatic Neoplasms
2
Melanoma
2
Lymphatic Abnormalities
2
Lymphangioma, Cystic
2
Lymphangioma
2
Hyperglycemia
2
Head and Neck Squamous Cell Cancer
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Advanced Breast Cancer
2
Vascular Malformations
1
Uveal Melanoma
1
Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein
1
Stomach Neoplasms
1
Solid Tumor
1
Skin Diseases, Vascular
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pre-menopausal Breast Cancer
1
Interventions
Insulin Glargine
4
Insulin
3
volagidemab
2
Metformin
2
Fulvestrant
2
Alpelisib
2
ziprasidone
1
relacorilant
1
pembrolizumab
1
exemestane
1
dapagliflozin
1
Vildagliptin
1
Tamoxifen
1
Standard of Care
1
Olanzapine
1
Letrozole
1
Insulin Lispro
1
Insulin Aspart
1
Injections
1
DNA, Ribosomal
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Hyperglycemia
×
Alpelisib
×
Clear all
NCT04300790
2025-07-29
METALLICA
MedSIR
Phase 2
Completed
69 enrolled
NCT04899349
2024-10-09
EPIK-B4
Novartis
Phase 2
Terminated
2 enrolled
8 charts